Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 35 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 11 | 616−3.5%/yr | −3.5%/yr | 3.21.0× | 9% | 590 in 2030−0.8%/yr |
| Lumbar fusion | 16 | 506−1.2%/yr | −1.2%/yr | 2.60.9× | 0% | 540 in 2030+1.1%/yr |
| Cervical fusion & disc arthroplasty | 4 | 238−0.9%/yr | −0.9%/yr | 1.21.0× | 0% | 270 in 2030+2.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 53 | 13,244+5.7%/yr | +5.7%/yr | 67.70.7× | 22% | 18,900 in 2030+6.1%/yr |
| Skin substitutes & wound grafts | 9 | 1,642+11%/yr | +11%/yr | 6.70.5× | 62% | 1,670 in 2030+0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 25 | 973−0.6%/yr | −0.6%/yr | 5.00.5× | 49% | 1,190 in 2030+3.4%/yr |
| Spinal cord & DRG stimulation | 3 | 110−6%/yr | −6%/yr | 0.60.9× | 17% | 90 in 2030−3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Superficial venous ablation | 6 | 568−13%/yr | −13%/yr | 2.90.5× | 94% | 490 in 2030−2.4%/yr |
| Peripheral arterial intervention | 5 | 334−8.2%/yr | −8.2%/yr | 1.70.3× | 0% | 370 in 2030+1.5%/yr |
| Dialysis access | 1 | 182−11%/yr | −11%/yr | 1.00.2× | 0% | 260 in 2030+6.4%/yr |
| Carotid revascularization | 4 | 162−1.2%/yr | −1.2%/yr | 0.81.0× | 0% | 170 in 2030+1.3%/yr |
| Thrombectomy, IVC filters & venous stents | 2 | 147+16%/yr | +16%/yr | 0.80.6× | 0% | 150 in 2030+0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 14 | 967−2.5%/yr | −2.5%/yr | 5.30.9× | 2% | 1,050 in 2030+1.3%/yr |
| Cholecystectomy & appendectomy | 9 | 685−6%/yr | −6%/yr | 3.71.0× | 2% | 740 in 2030+1.2%/yr |
| Colorectal resection | 2 | 340−0.4%/yr | −0.4%/yr | 1.81.3× | 0% | 360 in 2030+1%/yr |
| Antireflux & hiatal hernia surgery | 2 | 173+3.7%/yr | +3.7%/yr | 0.91.3× | 0% | 180 in 2030+0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 21 | 782−2.2%/yr | −2.2%/yr | 4.11.1× | 2% | 830 in 2030+1%/yr |
| BPH procedures | 12 | 679−16%/yr | −16%/yr | 3.60.8× | 7% | 580 in 2030−2.5%/yr |
| Hysterectomy, hysteroscopy & ablation | 7 | 426+5.8%/yr | +5.8%/yr | 2.41.0× | 8% | 720 in 2030+9.1%/yr |
| Incontinence, prolapse & sacral neuromodulation | 6 | 361+0.1%/yr | +0.1%/yr | 1.91.0× | 0% | 370 in 2030+0.3%/yr |
| Prostatectomy & nephrectomy | 6 | 237−1%/yr | −1%/yr | 1.31.1× | 0% | 280 in 2030+2.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 5 | 522+4.6%/yr | +4.6%/yr | 2.80.6× | 73% | 730 in 2030+5.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 12 | 694−8%/yr | −8%/yr | 3.80.6× | 5% | 810 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 28 | 4,887+30%/yr | +30%/yr | 25.41.3× | 42% | 8,940 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 15 | 883+1.5%/yr | +1.5%/yr | 4.71.2× | 0% | 880 in 20300%/yr |
| EP ablation | 10 | 763+16%/yr | +16%/yr | 3.61.2× | 0% | 1,730 in 2030+15%/yr |
| LAA occlusion & loop recorders | 12 | 395+13%/yr | +13%/yr | 1.90.7× | 0% | 760 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 18 | 1,037−8.8%/yr | −8.8%/yr | 4.91.1× | 0% | 1,380 in 2030+4.8%/yr |
| Structural heart (TAVR, TEER) | 15 | 357+1.6%/yr | +1.6%/yr | 1.71.1× | 0% | 480 in 2030+5.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| DBS & VNS | 1 | 133−4.9%/yr | −4.9%/yr | 0.72.2× | 0% | 140 in 2030+1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 31 | 9,758−0.6%/yr | −0.6%/yr | 50.71.1× | 83% | 10,100 in 2030+0.6%/yr |
| Vitreoretinal surgery | 5 | 349−0.8%/yr | −0.8%/yr | 1.80.7× | 51% | 340 in 2030−0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 43 | 13,022−1.4%/yr | −1.4%/yr | 69.90.7× | 21% | 14,500 in 2030+1.8%/yr |
| ERCP & endoscopic ultrasound | 8 | 373−4.1%/yr | −4.1%/yr | 2.00.6× | 0% | 440 in 2030+2.8%/yr |
| Bronchoscopy & lung nodule | 5 | 277+1.2%/yr | +1.2%/yr | 1.50.6× | 0% | 310 in 2030+1.7%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.